Epizyme Inc. buy melinda
Start price
14.06.17
/
50%
€11.84
Target price
22.06.17
€16.24
Performance (%)
10.06%
End price
22.06.17
€13.03
Summary
This prediction ended on 22.06.17 with a price of €13.03. The prediction had a final performance of 10.06%. melinda has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Epizyme Inc. | - | - | - | - |
| iShares Core DAX® | -0.436% | 1.181% | 14.210% | 57.331% |
| iShares Nasdaq 100 | 0.854% | 1.475% | 5.797% | 88.129% |
| iShares Nikkei 225® | 2.652% | 6.401% | 19.133% | 49.690% |
| iShares S&P 500 | 1.190% | 1.169% | 2.686% | 59.994% |
Comments by melinda for this prediction
In the thread Epizyme Inc. diskutieren
Gesundheit | Biotechnologie | Vereinigte Staaten
$$
(Vom Mitglied beendet)